{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:57:55Z","timestamp":1785851875330,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1053\/j.jvca.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:09:20Z","timestamp":1738800560000},"page":"1180-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of Hydroxycobolamin in the Prevention of Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass: A Controlled Prospective Trial"],"prefix":"10.1053","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5082-875X","authenticated-orcid":false,"given":"Dina","family":"Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondos","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2025.02.001_bib0001","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: current concepts and management","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0002","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0003-4975(01)02486-9","article-title":"Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function","volume":"71","author":"Mekontso-Dessap","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0003","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jtcvs.2003.09.046","article-title":"Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass","volume":"127","author":"Evora","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0004","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II dagger","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity","volume":"61","author":"Goradia","year":"2021","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2025.02.001_bib0006","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery: Review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.02.001_bib0007","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4103\/ija.IJA_379_17","article-title":"Basics of cardiopulmonary bypass","volume":"61","author":"Sarkar","year":"2017","journal-title":"Indian J Anaesth"},{"key":"10.1053\/j.jvca.2025.02.001_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2050312120935466","article-title":"Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies","volume":"8","author":"Barnes","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1053\/j.jvca.2025.02.001_bib0009","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.athoracsur.2006.08.041","article-title":"Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: A systematic literature review","volume":"83","author":"Egi","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2025.02.001_bib0011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0012","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0013","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(15)00273-1","article-title":"Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): A randomised, double-blind, placebo-controlled trial","volume":"386","author":"Whitlock","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2025.02.001_bib0014","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/jama.2012.14144","article-title":"Intraoperative high-dose dexamethasone for cardiac surgery: A randomized controlled trial","volume":"308","author":"Dieleman","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2025.02.001_bib0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.02.001_bib0016","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.jvca.2016.08.019","article-title":"Hydroxocobalamin as a rescue treatment for refractory vasoplegic syndrome after prolonged cardiopulmonary bypass","volume":"31","author":"Burnes","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.02.001_bib0017","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.02.001_bib0018","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","article-title":"The use of high-dose hydroxocobalamin for vasoplegic syndrome","volume":"97","author":"Roderique","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0019","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: Pathophysiology, risk factors and treatment","volume":"349","author":"Omar","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.jvca.2025.02.001_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery: Review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.02.001_bib0021","article-title":"Hydroxocobalamin for vasodilatory hypotension in shock: A systematic review with meta-analysis for the comparison to methylene blue","author":"Brokmeier","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.02.001_bib0022","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia: A review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.02.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000003648","article-title":"Use of hydroxocobalamin (vitamin B12a) in patients with vasopressor refractory hypotension after cardiopulmonary bypass: A case series","volume":"129","author":"Armour","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0024","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hrtlng.2020.11.003","article-title":"Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery","volume":"50","author":"Seelhammer","year":"2021","journal-title":"Heart Lung"},{"key":"10.1053\/j.jvca.2025.02.001_bib0025","article-title":"High-dose hydroxocobalamin for refractory vasoplegia post cardiac surgery","author":"Bak MA","year":"202214","journal-title":"Cureus"},{"key":"10.1053\/j.jvca.2025.02.001_bib0026","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/aca.ACA_88_17","article-title":"The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery","volume":"20","author":"Cai","year":"2017","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2025.02.001_bib0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: Early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0028","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1053\/j.jvca.2020.01.033","article-title":"Hydroxocobalamin versus methylene blue for vasoplegic syndrome in cardiothoracic surgery: A retrospective cohort","volume":"34","author":"Furnish","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.02.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2018.07.052","article-title":"Cardiopulmonary bypass ultrafiltrate discoloration after hydroxocobalamin administration","volume":"107","author":"Smith","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2025.02.001_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1213\/XAA.0000000000000928","article-title":"Use of high-dose hydroxocobalamin for septic shock: A case report","volume":"12","author":"Lin","year":"2019","journal-title":"AA Practice"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:39:35Z","timestamp":1744400375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077025001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1053077025001144"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2025.02.001","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Hydroxycobolamin in the Prevention of Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass: A Controlled Prospective Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}